Abstract
An analytical method for the quantitation of amifloxacin, 6-fluoro-1,4-dihydro-1-(methylamino)-7-(4-methyl-1-piperazinyl)-4-oxo-3- quinolinecarboxylic acid, in plasma and urine has been developed. The method involves extraction with chloroform, back-extraction into 0.1 M sodium hydroxide, and subsequent analysis by reverse-phase high-pressure liquid chromatography with UV detection. The precision of the assay calculated as the overall standard deviation was +/- 4.9% in plasma and +/- 1.1% in urine. The range of mean percent differences from the nominal values was used as an estimate of accuracy and was 93.6 to 103% of the nominal values in plasma and 95.2 to 107% of the nominal values in urine. The minimum quantifiable levels were 0.032 micrograms/ml in plasma and 2.7 micrograms/ml in urine. The methods were employed in a pharmacokinetic analysis of amifloxacin after intravenous administration to rhesus monkeys. The decline in drug plasma levels was described by a biexponential process with mean rates of 8.4 h-1 and 0.32 h-1 with corresponding half-lives of ca. 5 min and 2.2 h. Amifloxacin was rapidly excreted, with ca. 53% of the dose appearing in the urine within 48 h after medication. The mean renal clearance +/- standard deviation was 4.4 +/- 1.0 ml X kg-1 X min-1 and is compatible with passive glomerular filtration in this species.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Boppana V. K., Swanson B. N. Determination of norfloxacin, a new nalidixic acid analog, in human serum and urine by high-performance liquid chromatography. Antimicrob Agents Chemother. 1982 May;21(5):808–810. doi: 10.1128/aac.21.5.808. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cuisinaud G., Ferry N., Seccia M., Bernard N., Sassard J. Determination of nalidixic acid and its two major metabolites in human plasma and urine by reversed-phase high-performance liquid chromatography. J Chromatogr. 1980 Mar 14;181(3-4):399–406. doi: 10.1016/s0378-4347(00)81142-1. [DOI] [PubMed] [Google Scholar]
- Johnson J. A., Benziger D. P. Metabolism and disposition of amifloxacin in laboratory animals. Antimicrob Agents Chemother. 1985 May;27(5):774–781. doi: 10.1128/aac.27.5.774. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Koga H., Itoh A., Murayama S., Suzue S., Irikura T. Structure-activity relationships of antibacterial 6,7- and 7,8-disubstituted 1-alkyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acids. J Med Chem. 1980 Dec;23(12):1358–1363. doi: 10.1021/jm00186a014. [DOI] [PubMed] [Google Scholar]
- Kullberg M. P., Koss R., O'Neil S., Edelson J. High-performance liquid chromatographic analysis of rosoxacin and its N-oxide metabolite in plasma and urine. J Chromatogr. 1979 May 11;173(1):155–163. doi: 10.1016/s0021-9673(01)80455-6. [DOI] [PubMed] [Google Scholar]
- Montay G., Blain Y., Roquet F., Le Hir A. High-performance liquid chromatography of pefloxacin and its main active metabolites in biological fluids. J Chromatogr. 1983 Feb 11;272(2):359–365. doi: 10.1016/s0378-4347(00)86139-3. [DOI] [PubMed] [Google Scholar]
- Sorel R. H., Hulshoff A., Snelleman C. High-performance liquid chromatographic analysis of nalidixic acid and hydroxynalidixic acid in plasma with a dynamic anion-exchange system. J Chromatogr. 1980 Nov 14;221(1):129–137. doi: 10.1016/s0378-4347(00)81014-2. [DOI] [PubMed] [Google Scholar]
- Tisher C. C., Schrier R. W., McNeil J. S. Nature of urine concentrating mechanism in the macaque monkey. Am J Physiol. 1972 Nov;223(5):1128–1137. doi: 10.1152/ajplegacy.1972.223.5.1128. [DOI] [PubMed] [Google Scholar]